Tracheobronchial haemorrhage in patients with neuromuscular disorders

Francesca G Iodice1, Marco Salzano, Marcello Marri

  • 1Anaesthesia and Intensive care Department, Ospedale Bambino-Gesù- Palidoro, Via Torre di Palidoro, 00050 Fiumicino, Rome, Italy. Francesca_iodice@yahoo.it

Respiratory Medicine
|July 14, 2005
PubMed

Insights

Flexible tracheostomy tubes may reduce tracheal bleeding in patients with neuromuscular disorders. This study reviewed 49 patients with Duchenne muscular dystrophy (DMD) to evaluate tracheostomy tube safety.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory medicine
  • Neuromuscular disorders

Background:

  • Tracheostomy is a common procedure in patients with neuromuscular disorders.
  • Different types of tracheostomy tubes are available, each with potential complications.
  • Tracheal haemorrhages are a significant risk in this patient population.

Purpose of the Study:

  • To evaluate the safety and efficacy of different tracheostomy tube types in pediatric patients with neuromuscular disorders.
  • To identify factors associated with complications such as tracheal haemorrhages.
  • To provide evidence-based recommendations for tracheostomy tube selection in Duchenne muscular dystrophy (DMD) patients.

Main Methods:

  • Retrospective chart review of 49 patients diagnosed with Duchenne muscular dystrophy (DMD).
  • Analysis of tracheostomy tube types used and incidence of tracheal haemorrhages.
  • Data collected from the intensive care unit of Children's Hospital-Bambino Gesù, Rome, Italy.

Main Results:

  • Flexible tracheostomy tubes were associated with a lower incidence of tracheal haemorrhages compared to other types.
  • No significant difference in other complications was noted between tube types.
  • The study highlights the importance of careful tracheostomy tube selection.

Conclusions:

  • Flexible tracheostomy tubes appear to be a safer option for patients with Duchenne muscular dystrophy (DMD), potentially reducing the risk of tracheal haemorrhages.
  • Further prospective studies are warranted to confirm these findings.
  • Optimizing tracheostomy management is crucial for improving outcomes in pediatric patients with neuromuscular disorders.
Abstract

Related Concept Videos

Trachea01:22

Trachea

The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...